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In this pal~r we describe the construction f five mutants era bovine liver low Mr phosphotyrosine protein phosphatase (PTPase) expressed as
a fusion protein with the maltose binding protein in E. coli. Almost no changes inthe kinetic parameters were observed inthe fusion protein with 
respect to the native PTPase. Using oligonucleotide.directed mutagenesis Cys.17, Cys-62 and Cys-145 were converted toSet while Cys-12 was 
converted toboth Ser and Ala. The kinetic properties ofthe mutants, using p.nitrophenyl phosphate assubstrate, were compared with those of 
the nortnal protein fused with the maltose binding protein of E. coli; both of the Cys-12 mutants showed a complete loss of enzymatic a tivity while 
the specific activity of the Cys-I 7 mutant was greatly decreased (200-fold). The Cys-62 mutant showed a 2.5-fold ecrease in specific activity, while 
the Cys-145 mutant remained almost unchaJlged. These data confirm the involvement of Cys.12 and Cys-17 in the catalytic site and suggest that 
Cys-62 and Cys-145 mutations may destabilise the structure of the enzyme. 
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1. INTRODUCTION 
The cytosol of many tissues contains a low Mr acid 
phosphatase, orthophosphoric-monoester phosphohy- 
drolase (acid optimum), EC 3.1.3.2 [1]. This enzyme 
very efficiently catalyzes the hydrolysis of aryl phos- 
phates~ such as p-nitrophenyl phosphate and L-P-tyro- 
sine [2~3] and of acyl phosphates such as benzoyl phos- 
phate [4]. The enzyme possesses a very specific 
phosphotyrosine protein phosphatase activity, which 
can be demonstrated on several different substrates [5- 
7]. For this reason the enzyme is now called low M~ 
phosphotyrosyl protein phosphatase (PTPase). The en- 
zyme from bovine liver consists of a single polypeptide 
chain of 157 amino acid residues and contains eight 
cysteines, all in the reduced form [8]. Recently we have 
expressed the enzyme in £. coli: a polynucleotide se- 
quence synthesized on the basis of the protein primary 
structure was inserted into a bacterial expression vector 
[9]. A recent experiment of over-expression of the low 
Mr PTPase in v-erb.B transformed fibroblasts [1(3] 
seems to confirm PTPases as possible regulatory ele- 
ments of cell growth [11]. 
Several studies have been carried out in an attempt 
to identify the active site of the enzyme. Inactivation of 
the enzyme with iodoaeetate and protection with the 
competitive inhibitor, Pi [8], confirmed previous data [3] 
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about the presence of at least a half-eystine residue in 
or near the active site. Moreover, differential modifica- 
tion of the enzyme by [~4C]iodoacetate, in the presence 
or absence of Pa, showed that Cys-12 and Cys-17 gould 
be the two half-cystine residues involved in the active 
site of the molecule [8]. More recently We et al. [12] were 
able to trap a phosphoenzyme intermediate during the 
phosphatase-catalyzed r action. They also identified 
the nature of  the covalent intermediate as a cysteinyl 
phosphate. On the other hand, Zhang et al. [13], on the 
basis of covalent modification experiments, postulated 
the involvement of  Cys-62 and Cys-145 in the active site 
of the enzyme. In this paper we describe the mutagenesis 
of low M~ PTPase in four different cysteine residues. 
The results confirm the involvement ofCys-12 and Cys- 
17 in the active site of  the molecule. 
2. MATERIALS AND METHODS 
2.1. Materials 
En'ymes: Klenow frasraent of DNA polymerase l of £. eoli, 1"4 
DNA polymerase, T4 DNA ligase, polynucleotide kina~e and restric- 
tion enzymes were obtained from Bio-Rad; Taq polymerase from 
Promega, sequenase from USBC, and factor Xa from Biolabs New 
England and Sigma. 
Vectors: pMALc was from Biolabs New England. 
Plasmids: pGEMPTP [10], a derivative of pGEMSZI" vector 
(Promega), harbouring a chemically synth~iz~ polynacleotide ~-
quence coding for bovine liver low Mr Fl'Pase [9], was used. 
Bacterials strains: BW313 (dug-,ung-) was used for mutagencsis 
[14], and JMI01 [15] for pMALc recombinants. 
"~ . . . .  S:,,stem 200A Oligoaucleotides w~re synthesized usin~ a . . . . .  m ... 
DNA Synthesizer. Amylose resin was obtained from Biolabs New 
England. Gamma-[~"P]ATP (6,000 Ci/mmol~,:¢as obtained from NEN. 
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p-Nitrophenyl phosphate, angiotensin i and L-P-tyrosine were ob. 
tained from Sigma, Benzoyl phosphate was synthesized by ourselves 
according to Camici et al. [16]. Horseradish peroxidase.linked mouse 
anti-rabbit lg was obtained from Bio.R.ad. 
2.2. Methods 
Oligonucleotide-directed mutagenesis with the uridine method, ac- 
cording to Kunkel et al. [17], was perlbrmed on the pGEMPTP con- 
struct [10]. The TGC codons for Cys-I 2 and Cys- 17 were replaced with 
the TCC codon for serin¢ or (for Cys-12 only) with the GCC codon 
for alanine. The TGT codons for Cys-62 and Cys-145 were substituted 
with the TCT codon for serine. Mutations were confirmed by nucleo- 
tide sequence analysis. Polymerase chain reaction experiments for the 
insertion of the mutated sequences in pMALc vector [18] were per- 
formed according to Saiki et al. [19]: fl'agrnents spanning the entire 
coding sequence of normal ow M, PTPase and of the five mutated 
versions were obtained by amplification. The six different fragments 
were inserted into the unique Stul and Hindlll sites of the pMALe 
vector, downstream and in frame with the maltose binding protein 
coding sequence. After induction with isopropyl thiogalaetose, the 
expression of the six fusion proteins was obtained in E. coli; affinity 
purification on a Sepharose-amylose column [18] allowed us to obtain 
about 20 mg of fusion proteins per liter of culture, 
Phosphorylated angiotensin I was obtained using a partially puri- 
fied preparation of 1340 obtained from calf thymus [20]. 
SDS-PAGE was performed according to Laemmli et al. [21]. 
Enzymatic assays for p-nitrophenyl phosphate, benzoyl phosphate 
and L-P.tyrosine were performed according, respectively, to Hein- 
rikson et al. [2], Ramponi et al. [22] and Apostol et al. [23]. 
Western blot analysis was performed according to Tsan8 ¢t al. [24] 
using a rabbit anti-PTPase polyclonal antibody and horseradish per- 
o~idase-linked mouse anti-rabbit Ig as the second antibody. 
3. RESULTS AND DISCUSSION 
3.1. Mutagenesis and e.x-m'ession in the pMALc vector 
In vitro oligonucleotide-directed mutagenesis was 
performed on the pGEMPTP construct harbouring the 
low M~ PTPase coding sequence; five mutants were ob- 
tained, in which Cys-12 was substituted ither with alan- 
ine (CI2A mutant) or serine (C12S) and Cys-17, Cys-62 
and Cys-145 with serine (C17S, C62S and C145S). In 
order to facilitate purification, sequences coding for the 
normal and for the five mutated versions of the protein 
were inserted into pMALc [18]; this vector allows the 
efficient expression of an heterologous polypeptide in 
E. coli es a fusion protein, where the earboxyl terminus 
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Fig. I. SDS-PAGE (panel A) and Western blot analysis (panel B) of 
purilied maltose binding protein (MBP) fusion proteins: (1) native 
PTPase; (2) MBP; (3) MBP-PTPase; (4) MBP-CI2A', (5) MBP-CI2S; 
(6) MBP-CI 7S; (7) MBP.C62S; (8) MBP-CI45S; (9) raolecular weight 
standard, with the corresponding values expressed in kDa, Western 
blot analysis was carried out using rabbit anti-PTPase polyclonal 
antibody. 
of the maltose binding protein is linked to the amino 
terminus of the recombinant PTPase. 
An SDS-PAGE analysis stained with Coomassie blue 
and a Western blot analysis of the fusion proteins, puri- 
fied on an amylose-resin column0 are shown in Fig. 1: 
antibody recognition of PTPase is not impaired by the 
fusion with maltose binding protein. 
The purified fusion proteins were treated with factor 
Xa, which should separate the low Mr PTPase from the 
maltose binding protein by cutting the specific Ile-Glu- 
Gly-Arg sequence present at the joining point of the 
fusion protein. It has been reported [25] that factor Xa 
can cleave some proteins which do not contain the spe- 
cific tetrapeptide; this seems to be the case with low Mr 
Table I 
Comparison of specific activity and Km values of native lXl'Pase and PTPase fused to maltose binding protein (MBP) with different substrates 
Specific activity (U/rag) K., (raM) 
Native PTPa~e MBP-PTPase Native VrPas¢ MBP-PTPase 
p.Nitrophenyl phosphate 100,00 + 1,68 84.60 ± 2.83 0.27 +_ 0.03 0.27 +_ 0.01 
Benzoyl-phosphate (B-P) 52.72 + 1.35 39.70 ± 1,99 0.86 :t: 0.09 1,01 -t- 0,07 
L-P-Tyrosine 33.60 ± 2.99 27.42 +_ 1,81 
Tyr-phosphorylated 1,35 _+ 0.03 × 10 -3 1.02:1:0,01 × 10 -~ 
an,~otensin ! 
Data for K~ values and specific activity were representative of, respectively, three and five experiments. The specific activities of the fusion proteins 
were calculated eonsiderinl~ the M r of PTPase (29.9% of the M~ of the fusion protein). 
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PTPas¢, which is also internally cleaved by factor Xa, 
rendering purification of native protein very inefficient 
with this method (data not shown). 
3.2. Biochemical ssays with the fitsion protein 
It has been reported [26,27] that fusion proteins may 
maintain the biochemical or biological activity of the 
native protein. To test this, in a first experiment the 
catalytic actMty of low M~ PTPase purified from bovine 
liver and of the enzyme obtained as a fusion protein 
with maltose binding protein, was measured using p- 
nitrophenyl phosphate, L-P-tyrosine and Tyr- 
phosphorylated angiotensin I as substrates (Table I). 
The specific activity of the fusion protein shows a slight 
decrease (! 5-25%) using the three different substrates, 
whereas the Km value with p-nitrophenyl phosphate is 
almost identical to that of the native protein. On the 
basis of these results we can conclude that the fusion of 
~he low M~ PTPase with the maltose binding protein has 
a moderate influence on the kinetic properties of the 
enzyme, 
Recently Zhang et al. [13], on the basis of covalent 
modification experiments, proposed the involvement of 
Cys-62 and Cys-145 in the active site of the molecule, 
together with an unidentified arginine and histidine res- 
idue. The two mutants we obtained, C62S and C145S, 
show only a moderate decrease in specific activity, al- 
though to different extents (Table 11): with the first 
mutant we observe a 60% reduction compared to only 
an 18% reduction with the second mutant. Moreover, 
the/,C~ values of these two mutants remain in the same 
order of magnitude with respect o the normal protein. 
These results suggest a marginal involvement of Cys- 
145 and Cys-62 in the enzymatic activity. Alternatively 
we hypothesize that these two mutations destabilize the 
structure of the enzyme, causing a slight decrease in the 
enzymatic activity. 
Our results confirm that the active site is a complex 
structure where several residues can play a differential 
role in catalysis. On the other hand they confirm our 
previous findings [8] on the involvement of both Cys-12 
and Cys-17 in the active site of the enzyme. 
3.3. Biochemical assays with the mutated proteins 
The catalytic activity of the mutated fusion proteins 
on p-nitrophenyi phosphate was determined and com- 
pared to the values obtained with the normal PTPase 
fused with the maltose binding protein (Table II): sub- 
stitution of Cys-12 either with Ala (C12A) or Ser (C12S) 
resulted in a complete loss of activity, and therefore 
determination of kinetic parameters was not possible. 
In addition, the substitution of Cys-17 with serine 
(C 17S) led to a dramatic reduction (200-fold), although 
not to a complete loss of the enzymatic activity. The 
residual activity of Cl 7S mutant, together with the total 
loss of activity of the C12S mutant suggests a different 
involvement of these two residues in the catalytic mech- 
anism, in agreement with previous results [8], de- 
monstrating that Cys-12 is more reactive than Cys-17 
when compared with the iodoacetate alkylation reac- 
tion. On the basis of these results we can postulate a
direct invoh,ement of both residues in the catalytic site 
of the enzyme. 
Table II 
Specific activity and Km values of the normal and mutated P'l'Pases 
fusion proteins using p-nitropltenyl phosphate as substrate 
Specific activity K m PNPP 
PNPP (U/rag) (raM) 
MBP.PTPase 84.50 _ 2.83 0.27 + 0.03 
MBP-CI2A N.D. N.D. 
MBP-CI2S N,D, N.D. 
MBP-CI7S 0,44 + 0,04 3,:58 __. 0.08 
MBP-C625 33.51 ± 2.99 0.83 + 0.04 
. . . .  ~ t ~ 0.81 + 0.09 Lvi ~P-~I-,5S 69.66 ~- ,.,9 
Values were obtained as indicated in the legend to Table I. N.D,. not 
detectable. 
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